This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Murphy, S. J. Articles by Duckles, S. P. Search for Related Content PubMed PubMed Citation Articles by Murphy, S. J. Articles by Duckles, S. P. Related Collections Ischemic biology - basic studies Acute Cerebral Infarction Pathology of Stroke

(Stroke. 2000;31:1173.)
© 2000 American Heart Association, Inc.

Original Contributions

Progesterone Exacerbates Striatal Stroke Injury in Progesterone-Deficient Female Animals

Stephanie J. Murphy, VMD, PhD; Richard J. Traystman, PhD Patricia D. Hurn, PhD

From the Division of Comparative Medicine (S.J.M.) and Department of Anesthesiology and Critical Care Medicine (R.J.T., P.D.H.), Johns Hopkins University, School of Medicine, Baltimore, Md.

Correspondence to Stephanie J. Murphy, VMD, PhD, Johns Hopkins University, School of Medicine, Division of Comparative Medicine, 720 Rutland Ave, Baltimore, MD 21205-2196. E-mail murphyst{at}jhmi.edu

Background and Purpose—We have previously shown that female animals experience substantial protection from brain injury after reversible middle cerebral artery occlusion (MCAO) compared with their male or ovariectomized female counterparts. The reproductive steroid estrogen has been shown to provide neuroprotection from a variety of experimental insults, but the importance of progesterone as an anti-ischemic treatment has not been well explored. We evaluated histological outcomes after MCAO in ovariectomized female rats with or without acute or chronic progesterone replacement therapy.

Methods—Age-matched, adult female Wistar rats were ovariectomized and treated with 0, 30, or 60 mg/kg progesterone IP 30 minutes before ischemia (n=12 to 14 per group) or with 30 mg/kg progesterone IP daily for 7 to 10 days before ischemia (n=16). Each animal subsequently underwent 2 hours of MCAO with the intraluminal filament technique, followed by 22 hours of reperfusion. Ipsilateral parietal cortex perfusion was monitored with laser Doppler flowmetry throughout ischemia. Cortical, caudate-putamen, and hemispheric infarction volumes were determined with 2,3,5-triphenyltetrazolium chloride staining and digital image analysis.

Results—Intraischemic plasma progesterone levels were 5±3, 102±20,* 181±28,* and 133±25* ng/mL in the 0, 30, and 60 mg/kg acute progesterone group and the 30 mg/kg chronic progesterone group, respectively (*P<0.05 compared with 0 mg/kg). Caudate-putamen infarction volume (percent contralateral structure) was significantly increased by chronic progesterone treatment: 45.6±5.1%* in the 30 mg/kg chronic progesterone group and 29.2±5.3%, 35.8±5.1%, and 42.0±5.0% in the 0, 30, and 60 mg/kg acute progesterone groups, respectively (*P<0.05 compared with 0 mg/kg). Cortical and total hemispheric infarction volumes (percent contralateral structure) were unchanged by progesterone treatment.

Conclusions—Exogenous progesterone therapy does not ameliorate histological injury after MCAO in previously ovariectomized, adult female rats. Furthermore, chronic progesterone administration can exacerbate infarction in subcortical regions.

Editorial Comment

Sue Piper Duckles, PhD, Guest Editor

Department of Pharmacology University of California Irvine, California

This article has been cited by other articles:

				C. L Gibson, B. Coomber, and J. Rathbone Is Progesterone a Candidate Neuroprotective Factor for Treatment following Ischemic Stroke? Neuroscientist, August 1, 2009; 15(4): 324 - 332. [Abstract] [PDF]

				K. Vagnerova, I. P. Koerner, and P. D. Hurn Gender and the Injured Brain Anesth. Analg., July 1, 2008; 107(1): 201 - 214. [Abstract] [Full Text] [PDF]

				C. L. Gibson, L. J. Gray, P. M. W. Bath, and S. P. Murphy Progesterone for the treatment of experimental brain injury; a systematic review Brain, February 1, 2008; 131(2): 318 - 328. [Abstract] [Full Text] [PDF]

				M. Schumacher, R. Guennoun, A. Ghoumari, C. Massaad, F. Robert, M. El-Etr, Y. Akwa, K. Rajkowski, and E.-E. Baulieu Novel Perspectives for Progesterone in Hormone Replacement Therapy, with Special Reference to the Nervous System Endocr. Rev., June 1, 2007; 28(4): 387 - 439. [Abstract] [Full Text] [PDF]

				D. N. Krause, S. P. Duckles, and D. A. Pelligrino Influence of sex steroid hormones on cerebrovascular function J Appl Physiol, October 1, 2006; 101(4): 1252 - 1261. [Abstract] [Full Text] [PDF]

				K. M. Dhandapani and D. W. Brann Protective Effects of Estrogen and Selective Estrogen Receptor Modulators in the Brain Biol Reprod, November 1, 2002; 67(5): 1379 - 1385. [Abstract] [Full Text] [PDF]

				A. M. McNeill, C. Zhang, F. Z. Stanczyk, S. P. Duckles, and D. N. Krause Estrogen Increases Endothelial Nitric Oxide Synthase via Estrogen Receptors in Rat Cerebral Blood Vessels: Effect Preserved After Concurrent Treatment With Medroxyprogesterone Acetate or Progesterone Stroke, June 1, 2002; 33(6): 1685 - 1691. [Abstract] [Full Text] [PDF]